Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122421554 | 12242155 | 4 | F | 200501 | 20160822 | 20160406 | 20160829 | EXP | BR-PFIZER INC-2016194116 | PFIZER | 37.00 | YR | M | Y | 120.00000 | KG | 20160829 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122421554 | 12242155 | 1 | PS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 80 MG, 2X/DAY | 14042 | 20825 | 80 | MG | CAPSULE, HARD | BID | ||||||
| 122421554 | 12242155 | 2 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 2 TABLETS OF 80 MG, 2X/DAY | 20825 | 160 | MG | CAPSULE, HARD | BID | |||||||
| 122421554 | 12242155 | 3 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 80 MG, 2X/DAY | 20825 | 80 | MG | CAPSULE, HARD | BID | |||||||
| 122421554 | 12242155 | 4 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 80 MG, AT 1 TABLET IN THE MORNING AND 2 AT NIGHT | 20825 | CAPSULE, HARD | BID | |||||||||
| 122421554 | 12242155 | 5 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 2 TABLETS OF 40 MG IN THE MORNING AND 2 TABLETS OF 80 MG AT NIGHT | 20825 | CAPSULE, HARD | BID | |||||||||
| 122421554 | 12242155 | 6 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 1 TABLET OF 40 MG AND 2 TABLETS OF 80 MG AT NIGHT | 20825 | 200 | MG | CAPSULE, HARD | ||||||||
| 122421554 | 12242155 | 7 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 2 TABLETS OF 40 MG IN THE MORNING, 1 OF 40 MG AT LUNCH AND 2 TABLETS OF 80 MG AT NIGHT | 20825 | CAPSULE, HARD | TID | |||||||||
| 122421554 | 12242155 | 8 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 4 TABLETS OF STRENGTH 40MG AND 2 TABLETS OF STRENGTH 80MG PER DAY | 20825 | 320 | MG | CAPSULE, HARD | ||||||||
| 122421554 | 12242155 | 9 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | |||||||
| 122421554 | 12242155 | 10 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | STRENGTH 20 MG, 2 TABLETS/DAY | 0 | 40 | MG | TABLET | ||||||||
| 122421554 | 12242155 | 11 | C | RISPERIDONE. | RISPERIDONE | 1 | STRENGTH 3 MG, 3 TABLETS/DAY | 0 | 9 | MG | TABLET | ||||||||
| 122421554 | 12242155 | 12 | C | RISPERIDONE. | RISPERIDONE | 1 | 0 | TABLET | |||||||||||
| 122421554 | 12242155 | 13 | C | TEGRETOL CR | CARBAMAZEPINE | 1 | 200 MG 3 TABLETS PER DAY | 0 | 600 | MG | TABLET | ||||||||
| 122421554 | 12242155 | 14 | C | TEGRETOL CR | CARBAMAZEPINE | 1 | 0 | TABLET | |||||||||||
| 122421554 | 12242155 | 15 | C | CLOMIPRAMINE | CLOMIPRAMINE | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | BID | ||||||||
| 122421554 | 12242155 | 16 | C | CLOMIPRAMINE | CLOMIPRAMINE | 1 | 0 | ||||||||||||
| 122421554 | 12242155 | 17 | C | ENALAPRIL | ENALAPRIL | 1 | 10 MG 3 TABLETS/DAY | 0 | 30 | MG | TABLET | ||||||||
| 122421554 | 12242155 | 18 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | |||||||
| 122421554 | 12242155 | 19 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | |||||||
| 122421554 | 12242155 | 20 | C | AKINETON | BIPERIDEN HYDROCHLORIDE | 1 | 2 MG, 2X/DAY | 0 | 2 | MG | BID | ||||||||
| 122421554 | 12242155 | 21 | C | AKINETON | BIPERIDEN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122421554 | 12242155 | 22 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 1 TABLET IN THE MORNING | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122421554 | 12242155 | 1 | Schizophrenia |
| 122421554 | 12242155 | 9 | Schizophrenia |
| 122421554 | 12242155 | 10 | Obsessive-compulsive disorder |
| 122421554 | 12242155 | 11 | Schizophrenia |
| 122421554 | 12242155 | 12 | Obsessive-compulsive disorder |
| 122421554 | 12242155 | 13 | Schizophrenia |
| 122421554 | 12242155 | 14 | Obsessive-compulsive disorder |
| 122421554 | 12242155 | 15 | Schizophrenia |
| 122421554 | 12242155 | 16 | Obsessive-compulsive disorder |
| 122421554 | 12242155 | 17 | Blood pressure abnormal |
| 122421554 | 12242155 | 18 | Blood cholesterol abnormal |
| 122421554 | 12242155 | 19 | Prophylaxis |
| 122421554 | 12242155 | 20 | Schizophrenia |
| 122421554 | 12242155 | 21 | Obsessive-compulsive disorder |
| 122421554 | 12242155 | 22 | Abdominal discomfort |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122421554 | 12242155 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122421554 | 12242155 | Aggression | |
| 122421554 | 12242155 | Intentional product use issue | |
| 122421554 | 12242155 | Physical assault | |
| 122421554 | 12242155 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122421554 | 12242155 | 1 | 200409 | 0 | ||
| 122421554 | 12242155 | 2 | 200501 | 2005 | 0 | |
| 122421554 | 12242155 | 3 | 2005 | 2005 | 0 | |
| 122421554 | 12242155 | 4 | 2005 | 0 | ||
| 122421554 | 12242155 | 5 | 2013 | 0 | ||
| 122421554 | 12242155 | 7 | 201603 | 2016 | 0 | |
| 122421554 | 12242155 | 8 | 2016 | 0 | ||
| 122421554 | 12242155 | 9 | 2004 | 0 | ||
| 122421554 | 12242155 | 11 | 2004 | 0 | ||
| 122421554 | 12242155 | 15 | 2004 | 0 | ||
| 122421554 | 12242155 | 22 | 200411 | 0 |